Michael W. Nall
2019
In 2019, Michael W. Nall earned a total compensation of $1.2M as President and Chief Executive Officer at Biocept, a 177% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $154,000 |
|---|---|
| Option Awards | $617,493 |
| Salary | $434,962 |
| Other | $9,600 |
| Total | $1,216,055 |
Nall received $617.5K in option awards, accounting for 51% of the total pay in 2019.
Nall also received $154K in non-equity incentive plan, $435K in salary and $9.6K in other compensation.
Rankings
In 2019, Michael W. Nall's compensation ranked 8,370th out of 13,971 executives tracked by ExecPay. In other words, Nall earned more than 40.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,370 out of 13,971 | 40th |
Division Services | 1,577 out of 2,389 | 34th |
Major group Health Services | 145 out of 237 | 39th |
Industry group Medical And Dental Laboratories | 39 out of 75 | 48th |
Industry Medical Laboratories | 39 out of 75 | 48th |
Source: SEC filing on April 29, 2020.
Nall's colleagues
We found two more compensation records of executives who worked with Michael W. Nall at Biocept in 2019.